These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 15536230

  • 1. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects.
    Astrup A, Caterson I, Zelissen P, Guy-Grand B, Carruba M, Levy B, Sun X, Fitchet M.
    Obes Res; 2004 Oct; 12(10):1658-69. PubMed ID: 15536230
    [Abstract] [Full Text] [Related]

  • 2. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group.
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [Abstract] [Full Text] [Related]

  • 3. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.
    Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH.
    Obes Res; 2003 Jun; 11(6):722-33. PubMed ID: 12805393
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.
    Tonstad S, Tykarski A, Weissgarten J, Ivleva A, Levy B, Kumar A, Fitchet M.
    Am J Cardiol; 2005 Jul 15; 96(2):243-51. PubMed ID: 16018851
    [Abstract] [Full Text] [Related]

  • 5. Topiramate: a new potential pharmacological treatment for obesity.
    Astrup A, Toubro S.
    Obes Res; 2004 Dec 15; 12 Suppl():167S-73S. PubMed ID: 15687413
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.
    Rosenstock J, Hollander P, Gadde KM, Sun X, Strauss R, Leung A, OBD-202 Study Group.
    Diabetes Care; 2007 Jun 15; 30(6):1480-6. PubMed ID: 17363756
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
    Toplak H, Hamann A, Moore R, Masson E, Gorska M, Vercruysse F, Sun X, Fitchet M.
    Int J Obes (Lond); 2007 Jan 15; 31(1):138-46. PubMed ID: 16703004
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 15; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 9. Phentermine/topiramate for the treatment of obesity.
    Smith SM, Meyer M, Trinkley KE.
    Ann Pharmacother; 2013 Mar 15; 47(3):340-9. PubMed ID: 23482732
    [Abstract] [Full Text] [Related]

  • 10. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.
    Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH.
    Am J Clin Nutr; 2012 Feb 15; 95(2):297-308. PubMed ID: 22158731
    [Abstract] [Full Text] [Related]

  • 11. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B, Gudbjörnsdottir S, Cederholm J, Liang Y, Vercruysse F, Smith U.
    Int J Obes (Lond); 2007 Jul 15; 31(7):1140-7. PubMed ID: 17264849
    [Abstract] [Full Text] [Related]

  • 12. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM, Balance Study Group.
    Eur J Clin Nutr; 2005 Aug 15; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 15; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 14. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
    Gadde KM, Parker CB, Maner LG, Wagner HR, Logue EJ, Drezner MK, Krishnan KR.
    Obes Res; 2001 Sep 15; 9(9):544-51. PubMed ID: 11557835
    [Abstract] [Full Text] [Related]

  • 15. Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2).
    Davidson MH, Tonstad S, Oparil S, Schwiers M, Day WW, Bowden CH.
    Am J Cardiol; 2013 Apr 15; 111(8):1131-8. PubMed ID: 23375187
    [Abstract] [Full Text] [Related]

  • 16. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
    Kiortsis DN.
    Hormones (Athens); 2013 Apr 15; 12(4):507-16. PubMed ID: 24457398
    [Abstract] [Full Text] [Related]

  • 17. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.
    Diabetes Obes Metab; 2005 Nov 15; 7(6):699-708. PubMed ID: 16219013
    [Abstract] [Full Text] [Related]

  • 18. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A.
    Diabetes Care; 2007 Jan 15; 30(1):27-32. PubMed ID: 17192328
    [Abstract] [Full Text] [Related]

  • 19. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL, Apovian CM, Aronne LJ, Fernstrom MH, Frank A, Greenway FL, Heber D, Kushner RF, Cwik KM, Walch JK, Hewkin AC, Blakesley V.
    Obesity (Silver Spring); 2007 Jun 15; 15(6):1464-72. PubMed ID: 17557984
    [Abstract] [Full Text] [Related]

  • 20. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
    Tremblay A, Chaput JP, Bérubé-Parent S, Prud'homme D, Leblanc C, Alméras N, Després JP.
    Eur J Clin Pharmacol; 2007 Feb 15; 63(2):123-34. PubMed ID: 17200837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.